High Growth Tech Stocks In The US For May 2026

Simply Wall St.05-13

The United States market has experienced a 1.5% increase over the last week and a substantial 26% rise over the past year, with earnings projected to grow by 17% annually. In this thriving environment...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635279789?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","is_english":true,"pubTime":"2026-05-13 19:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635279789","market":"sg","top_or_hot":-1,"title":"High Growth Tech Stocks In The US For May 2026","media":"Simply Wall St.","content":"<div>\n<p>The United States market has experienced a 1.5% increase over the last week and a substantial 26% rise over the past year, with earnings projected to grow by 17% annually. In this thriving environment...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntla/intellia-therapeutics/news/high-growth-tech-stocks-in-the-us-for-may-2026\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>High Growth Tech Stocks In The US For May 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHigh Growth Tech Stocks In The US For May 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-13 19:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntla/intellia-therapeutics/news/high-growth-tech-stocks-in-the-us-for-may-2026><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The United States market has experienced a 1.5% increase over the last week and a substantial 26% rise over the past year, with earnings projected to grow by 17% annually. In this thriving environment...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntla/intellia-therapeutics/news/high-growth-tech-stocks-in-the-us-for-may-2026\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4613","symbol_name":"AI应用软件","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntla/intellia-therapeutics/news/high-growth-tech-stocks-in-the-us-for-may-2026","article_id":"2635279789","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntla/intellia-therapeutics/news/high-growth-tech-stocks-in-the-us-for-may-2026","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2635279789","pubTimestamp":1778670486,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"The United States market has experienced a 1.5% increase over the last week and a substantial 26% rise over the past year, with earnings projected to grow by 17% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies that demonstrate robust innovation and adaptability to capitalize on these favorable conditions.","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4613":"AI应用软件","IE00B894F039.SGD":"Legg Mason ClearBridge - US Aggressive Growth A Acc SGD-H","IE00B19Z9P08.USD":"LEGG MASON CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (USD) INC","NTLA":"Intellia Therapeutics Inc","BK4535":"淡马锡持仓","LU2250418816.HKD":"BGF WORLD TECHNOLOGY \"A\" (HKD) ACC","LU1861558580.USD":"日兴方舟颠覆性创新基金B","LU2063271972.USD":"富兰克林创新领域基金","BK4588":"碎股","LU2360106780.USD":"BGF WORLD TECHNOLOGY \"A4\" (USD) INC","LU2360107168.USD":"BGF NEXT GENERATION TECHNOLOGY \"A4\" (USD) INC","LU2290526834.HKD":"BGF NEXT GENERATION TECHNOLOGY \"A2\" (HKDHDG) ACC","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc","IE00BZ9MQY76.HKD":"FTGF CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (HKD) ACC","BK4608":"AI应用概念股","LU2087625088.SGD":"ALLSPRING  US ALL CAP GROWTH \"A\" (SGDHDG) ACC","APP":"AppLovin Corporation","APPX":"2倍做多APP ETF-Tradr","BK4539":"次新股","LU1861215975.USD":"贝莱德新一代科技基金 A2","BK4023":"应用软件","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","LU0353189763.USD":"ALLSPRING  US ALL CAP GROWTH FUND \"I\" (USD) ACC","LU1861220033.SGD":"Blackrock Next Generation Technology A2 SGD-H","LPTH":"LightPath Technologies","IE00B19Z9Z06.USD":"Legg Mason ClearBridge - US Aggressive Growth A Acc USD","BK4585":"ETF&股票定投概念","BK4556":"基因编辑","LU0056508442.USD":"贝莱德世界科技基金A2","BK4139":"生物科技","LU0097036916.USD":"贝莱德美国增长A2 USD","BK4157":"电子设备和仪器","LU1852331112.SGD":"Blackrock World Technology Fund A2 SGD-H"},"translate_title":"2026年5月美国高增长科技股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LPTH":1.92,"NTLA":1.91,"APPX":0.6,"APP":1.89},"content_text":"The United States market has experienced a 1.5% increase over the last week and a substantial 26% rise over the past year, with earnings projected to grow by 17% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies that demonstrate robust innovation and adaptability to capitalize on these favorable conditions.AdvertisementTop 10 High Growth Tech Companies In The United StatesNameRevenue GrowthEarnings GrowthGrowth RatingAppLovin20.89%21.43%★★★★★★Reddit21.88%24.69%★★★★★★Krystal Biotech29.09%36.48%★★★★★★Palantir Technologies29.33%30.33%★★★★★★Fabrinet21.38%23.34%★★★★★★Marker Therapeutics61.33%65.71%★★★★★★Gorilla Technology Group54.35%96.69%★★★★★☆Intellia Therapeutics57.31%64.37%★★★★★☆Zscaler15.95%49.84%★★★★★☆Circle Internet Group21.46%52.63%★★★★★☆Click here to see the full list of 61 stocks from our US High Growth Tech and AI Stocks screener.Here we highlight a subset of our preferred stocks from the screener.LightPath Technologies (LPTH)Simply Wall St Growth Rating: ★★★★★☆Overview: LightPath Technologies, Inc. is a company that designs, develops, manufactures, and distributes optical systems and assemblies in the United States with a market capitalization of $739.54 million.Operations: LightPath Technologies focuses on the design, development, manufacturing, and distribution of optical systems and assemblies.LightPath Technologies has demonstrated a robust annual revenue growth of 36.2%, significantly outpacing the broader U.S. market's average of 11.6%. This growth is underpinned by strategic expansions like the recent GSA Multiple Award Schedule contract, enhancing its governmental reach, and the appointment of Doug Schoen, which strengthens its leadership in global sales with his extensive aerospace and defense industry experience. Despite current unprofitability and substantial shareholder dilution over the past year, LightPath is poised for profitability within three years with an expected earnings surge of 122.64% annually. These developments suggest a potentially bright future as it navigates towards operational profitability while expanding its technological footprint in high-demand sectors.Navigate through the intricacies of LightPath Technologies with our comprehensive health report here.Evaluate LightPath Technologies' historical performance by accessing our past performance report.LPTH Earnings and Revenue Growth as at May 2026Intellia Therapeutics (NTLA)Simply Wall St Growth Rating: ★★★★★☆Overview: Intellia Therapeutics, Inc. is a clinical-stage genome editing company dedicated to developing potentially curative therapeutics using CRISPR/Cas9-based technologies, with a market cap of $2.01 billion.Operations: Intellia Therapeutics focuses on developing therapeutics using CRISPR/Cas9 technology. The company is in the clinical stage, indicating that its primary activities involve research and development rather than generating revenue from product sales.Intellia Therapeutics, amid substantial shareholder dilution, reported a narrowing net loss from $114.33 million to $96.23 million year-over-year for Q1 2026, reflecting tighter cost management and strategic R&D investments which totaled $180 million in recent equity offerings aimed at advancing CRISPR technologies. The firm's recent HAELO trial success with lonvo-z showcased a significant reduction in hereditary angioedema attacks, positioning it potentially as the first one-time gene-editing treatment in this category. Despite current unprofitability, Intellia's aggressive pursuit of innovative treatments underscores its potential pivotal role in transforming therapeutic standards and patient outcomes in genetic diseases.Delve into the full analysis health report here for a deeper understanding of Intellia Therapeutics.Gain insights into Intellia Therapeutics' historical performance by reviewing our past performance report.NTLA Revenue and Expenses Breakdown as at May 2026AppLovin (APP)Simply Wall St Growth Rating: ★★★★★★Overview: AppLovin Corporation offers comprehensive AI-driven advertising solutions globally, with a market cap of $160.72 billion.Operations: The company generates revenue primarily through its advertising segment, which brought in $6.16 billion.AppLovin's recent performance underscores its robust position in the tech sector, with Q1 2026 sales soaring to $1.84 billion from $1.16 billion year-over-year, and net income more than doubling to $1.21 billion. This financial upswing is complemented by strategic share repurchases, with 2.17 million shares bought back in the first quarter alone, emphasizing confidence in its operational stability and future growth prospects. Furthermore, the company's aggressive R&D focus not only fuels innovation but also aligns with industry shifts towards advanced software solutions, ensuring AppLovin remains at the forefront of technological advancements and market demands.Get an in-depth perspective on AppLovin's performance by reading our health report here.Explore historical data to track AppLovin's performance over time in our Past section.APP Revenue and Expenses Breakdown as at May 2026Key TakeawaysUnlock more gems!  Our US High Growth Tech and AI Stocks screener has unearthed 58 more companies for you to explore.Click here to unveil our expertly curated list of 61 US High Growth Tech and AI Stocks.Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.Ready For A Different Approach?Explore high-performing small cap companies that haven't yet garnered significant analyst attention.Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.Find companies with promising cash flow potential yet trading below their fair value.  This article by Simply Wall St is general in nature. We provide commentary based on historical data \n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your \n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data. \n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. \n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635279789","isCrawlerRequest":true}